EC 603-721-4
Also known as Chrysotile, Amosite, Crocidolite, Tremolite, Anthophyllite and 1 more.
Sales rose 14% to ¥1,004.2bn; core operating income doubled to ¥114.1bn. Semiconductor demand, higher prices, FX and Middle East-driven naphtha effects boosted performance.
KRW 600 billion plant adds 2.5 Mtpa low‑carbon capacity; scrap-based EAF cuts CO2 ~75% vs POSCO 2017–19 baseline; supports premium EAF steel and HyREX transition.
JASCAYD® (nerandomilast) gains approval in China for progressive pulmonary fibrosis, offering a new treatment option after five years, based on successful Phase III trials.
